NK cell markers predict the efficacy of IV immunoglobulins in CIDP

OBJECTIVE: To assess whether IV immunoglobulins (IVIgs) as a first-line treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) have a regulative effect on natural killer (NK) cells that is related to clinical responsiveness to IVIg. METHODS: In a prospective longitudinal study, we co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Neuroimmunol Neuroinflamm
Main Authors: Mausberg, Anne K., Heininger, Maximilian K., Meyer Zu Horste, Gerd, Cordes, Steffen, Fleischer, Michael, Szepanowski, Fabian, Kleinschnitz, Christoph, Hartung, Hans-Peter, Kieseier, Bernd C., Stettner, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577535/
https://ncbi.nlm.nih.gov/pubmed/33008921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000884
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados